Showing results (311-320 of 323) with videos related to
Sort By:
Pageof 33
Angewandte Chemie (International Ed. in English)|March 30, 2021
25 Years of Reticular ChemistryRalph Freund, Stefano Canossa, Seth M Cohen, et al.Journal of Medicinal Chemistry|August 16, 2017
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1Allie Y Chen, Pei W Thomas, Alesha C Stewart, et al.Journal of the American College of Surgeons|November 24, 2007
Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studiesJ Pieter Noordzij, Stephanie L Lee, Victor J Bernet, et al.Chemical Science|April 19, 2019
Flux melting of metal-organic frameworksLouis Longley, Sean M Collins, Shichun Li, et al.Nature Materials|March 20, 2019
Pressure promoted low-temperature melting of metal-organic frameworksRemo N Widmer, Giulio I Lampronti, Simone Anzellini, et al.Nature Chemical Biology|March 1, 2017
Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11Jing Li, Tanya Yakushi, Francesco Parlati, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial CancerMaria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 5, 2009
Clinical practice guideline: hoarseness (dysphonia)Seth R Schwartz, Seth M Cohen, Seth H Dailey, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with SarcomaSujana Movva, Kenneth Seier, Viswatej Avutu, et al.Journal for Immunotherapy of Cancer|June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcomaSujana Movva, Kenneth Seier, Martina Bradic, et al.Pageof 33